Journal of Medicinal Chemistry, volume 55, issue 5, pages 1957-1968
Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines
Mark O’Connor
1
,
Andrew Kellett
1
,
Malachy McCann
2
,
Georgina M. Rosair
3
,
MARY MCNAMARA
1
,
Orla Howe
1
,
B. Creaven
4
,
SIOBHAN McCLEAN
4
,
Agnieszka Foltyn Arfa Kia
4
,
Denis O’Shea
1
,
Michael Devereux
1
1
The Inorganic Pharmaceutical
and Biomimetic Research Centre, Focas Research Institute, Dublin Institute of Technology, Camden Row, Dublin
8, Ireland
|
2
Chemistry Department, National University of Ireland, Maynooth, County Kildare,
Ireland
|
4
Centre of
Applied Science for
Health, Institute of Technology Tallaght Dublin, Tallaght, Dublin 24, Ireland
|
Publication type: Journal Article
Publication date: 2012-02-28
Journal:
Journal of Medicinal Chemistry
Quartile SCImago
Q1
Quartile WOS
Q1
SJR: 1.986
CiteScore: 12.8
Impact factor: 6.8
ISSN: 00222623, 15204804
Drug Discovery
Molecular Medicine
Abstract
The complexes [Cu(salH)(2)(H(2)O)] (1), [Cu(dipsH)(2)(H(2)O)] (2), {Cu(3-MeOsal)(H(2)O)(0.75)}(n) (3), [Cu(dipsH)(2)(BZDH)(2)] (4), [Cu(dipsH)(2)(2-MeOHBZDH)(2)]·EtOH (5), [Cu(sal)(phen)] (6), [Cu(dips)(phen)]·H(2)O (7), and [Cu(3-MeOsal)(phen)]·H(2)O (8) (salH(2) = salicylic acid; dipsH(2) = 3,5-diisopropylsalicylic acid; 3-MeOsalH(2) = 3-methoxysalicylic acid; BZDH = benzimidazole; 2-MeOHBZDH = 2 methanolbenzimidazole and phen =1,10-phenanthroline) were prepared and characterized. Structures of 4, 5, and 8 were determined by X-ray crystallography. Compounds 1-8 are potent superoxide dismutase mimetics, and they are inactive as inhibitors of COX-2 activity. Compounds 1, 4, and 5 exhibit moderate inhibition of COX-1. Complexes 6-8 display rapid micromolar cytotoxicity against cisplatin sensitive (breast (MCF-7), prostate (DU145), and colon (HT29)) and cisplatin resistant (ovarian (SK-OV-3)) cell lines compared to 1-5, and they exhibit potent in vitro DNA binding and cleavage capabilities.
Top-30
Journals
2
4
6
8
10
12
14
16
18
|
|
Journal of Inorganic Biochemistry
17 publications, 11.64%
|
|
Polyhedron
9 publications, 6.16%
|
|
Inorganica Chimica Acta
7 publications, 4.79%
|
|
Journal of Molecular Structure
7 publications, 4.79%
|
|
European Journal of Medicinal Chemistry
6 publications, 4.11%
|
|
RSC Advances
5 publications, 3.42%
|
|
Dalton Transactions
5 publications, 3.42%
|
|
Journal of Coordination Chemistry
5 publications, 3.42%
|
|
New Journal of Chemistry
4 publications, 2.74%
|
|
Molecules
4 publications, 2.74%
|
|
Journal of Biological Inorganic Chemistry
4 publications, 2.74%
|
|
Applied Organometallic Chemistry
4 publications, 2.74%
|
|
Journal of Structural Chemistry
4 publications, 2.74%
|
|
Inorganic Chemistry Communication
3 publications, 2.05%
|
|
Zeitschrift fur Anorganische und Allgemeine Chemie
3 publications, 2.05%
|
|
Chemistry - A European Journal
3 publications, 2.05%
|
|
Current Medicinal Chemistry
2 publications, 1.37%
|
|
Frontiers in Chemistry
2 publications, 1.37%
|
|
International Journal of Molecular Sciences
2 publications, 1.37%
|
|
Scientific Reports
2 publications, 1.37%
|
|
Journal of Solid State Chemistry
2 publications, 1.37%
|
|
Coordination Chemistry Reviews
2 publications, 1.37%
|
|
Chemical Biology and Drug Design
2 publications, 1.37%
|
|
European Journal of Inorganic Chemistry
2 publications, 1.37%
|
|
Inorganic Chemistry
2 publications, 1.37%
|
|
Bioinorganic Chemistry and Applications
2 publications, 1.37%
|
|
Mendeleev Communications
1 publication, 0.68%
|
|
Russian Journal of Inorganic Chemistry
1 publication, 0.68%
|
|
Oncotarget
1 publication, 0.68%
|
|
2
4
6
8
10
12
14
16
18
|
Publishers
10
20
30
40
50
60
70
|
|
Elsevier
62 publications, 42.47%
|
|
Wiley
18 publications, 12.33%
|
|
Royal Society of Chemistry (RSC)
15 publications, 10.27%
|
|
Springer Nature
11 publications, 7.53%
|
|
MDPI
8 publications, 5.48%
|
|
American Chemical Society (ACS)
7 publications, 4.79%
|
|
Pleiades Publishing
5 publications, 3.42%
|
|
Taylor & Francis
5 publications, 3.42%
|
|
Bentham Science Publishers Ltd.
2 publications, 1.37%
|
|
Frontiers Media S.A.
2 publications, 1.37%
|
|
IOP Publishing
2 publications, 1.37%
|
|
Hindawi Limited
2 publications, 1.37%
|
|
Impact Journals
1 publication, 0.68%
|
|
Chinese Academy of Sciences
1 publication, 0.68%
|
|
Walter de Gruyter
1 publication, 0.68%
|
|
AIP Publishing
1 publication, 0.68%
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.68%
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
O’Connor M. et al. Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines // Journal of Medicinal Chemistry. 2012. Vol. 55. No. 5. pp. 1957-1968.
GOST all authors (up to 50)
Copy
O’Connor M., Kellett A., McCann M., Rosair G. M., MCNAMARA M., Howe O., Creaven B., McCLEAN S., Foltyn Arfa Kia A., O’Shea D., Devereux M. Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines // Journal of Medicinal Chemistry. 2012. Vol. 55. No. 5. pp. 1957-1968.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/jm201041d
UR - https://doi.org/10.1021/jm201041d
TI - Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines
T2 - Journal of Medicinal Chemistry
AU - McCann, Malachy
AU - MCNAMARA, MARY
AU - Foltyn Arfa Kia, Agnieszka
AU - O’Shea, Denis
AU - O’Connor, Mark
AU - Kellett, Andrew
AU - Rosair, Georgina M.
AU - Howe, Orla
AU - Creaven, B.
AU - McCLEAN, SIOBHAN
AU - Devereux, Michael
PY - 2012
DA - 2012/02/28
PB - American Chemical Society (ACS)
SP - 1957-1968
IS - 5
VL - 55
SN - 0022-2623
SN - 1520-4804
ER -
Cite this
BibTex
Copy
@article{2012_O’Connor,
author = {Malachy McCann and MARY MCNAMARA and Agnieszka Foltyn Arfa Kia and Denis O’Shea and Mark O’Connor and Andrew Kellett and Georgina M. Rosair and Orla Howe and B. Creaven and SIOBHAN McCLEAN and Michael Devereux},
title = {Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines},
journal = {Journal of Medicinal Chemistry},
year = {2012},
volume = {55},
publisher = {American Chemical Society (ACS)},
month = {feb},
url = {https://doi.org/10.1021/jm201041d},
number = {5},
pages = {1957--1968},
doi = {10.1021/jm201041d}
}
Cite this
MLA
Copy
O’Connor, Mark, et al. “Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines.” Journal of Medicinal Chemistry, vol. 55, no. 5, Feb. 2012, pp. 1957-1968. https://doi.org/10.1021/jm201041d.